Semavic®

Semavic® is a complete analogue of Ozempic by Novo Nordisk, having the same composition and exactly the same effectiveness. Semavic® is manufactured in Russia under strict control of Russian authorities , it's indicated for use in adult patients with type 2 diabetes mellitus during diet and exercise to improve glycemic control. Semavic® reduces sugar to normal values, dulls the feeling of hunger and significantly reduces weight.
One pack of Semavic® contains 1 pre-filled pen of 3ml + 4 needles. The pen provides injections of 1ml, 0.5ml or 0.25ml.

Semavic® is used once a week at any time, regardless of food intake. Semavic® is injected subcutaneously into the abdomen, thigh or shoulder. The injection site can be changed without dose adjustment. Semavic® cannot be administered intravenously or intramuscularly.